Bill Text: NY A05218 | 2023-2024 | General Assembly | Introduced

---

Bill Title: Designates an individual to be notified in the case of dose or brand change for psychotropic medication.

Spectrum: Partisan Bill (Republican 6-0)

Status: (Introduced) 2024-01-03 - referred to health [A05218 Detail]

Download: New_York-2023-A05218-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          5218

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                      March 7, 2023
                                       ___________

        Introduced   by  M.  of  A.  BARCLAY,  MANKTELOW,  LEMONDES,  DeSTEFANO,
          J. M. GIGLIO, BLANKENBUSH -- read once and referred to  the  Committee
          on Health

        AN  ACT  to  amend  the public health law, in relation to designating an
          individual to be notified in the case of  dose  or  brand  change  for
          psychotropic medication

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 3 of section 2803-c of the public health law is
     2  amended by adding a new paragraph s to read as follows:
     3    s. (i) Pursuant to regulations promulgated by the commissioner,  every
     4  patient  shall  have the right to designate an individual to be notified
     5  in the event that the facility reduces the dose or changes the brand  or
     6  form  of  the patient's psychotropic medication. Such notification shall
     7  include a warning listing possible side effects and  drug  interactions,
     8  including  side effects upon discontinuation of such drugs. Notification
     9  shall be made in writing, and shall not be effective  until  receipt  of
    10  the written consent of the designated individual. In the case of a grad-
    11  ual  dose  reduction,  a  designee  shall check a box acknowledging such
    12  designee has been given a copy of the rights pertaining to gradual  dose
    13  reductions.
    14    (ii)  For  the  purposes  of this paragraph, "psychotropic medication"
    15  means a medication that is administered for  the  purpose  of  affecting
    16  brain  activities associated with mental processes and behavior, includ-
    17  ing, but not limited to, anti-psychotics, anti-depressants, anxiolytics,
    18  sedatives and hypnotics.
    19    § 2. This act shall take effect on the one hundred eightieth day after
    20  it shall have become a law.


         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD04918-01-3